|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC715|
|Submitter :||Mr. Greg Piepel||Date & Time:||10/12/2005 06:10:59|
|Organization :||Mr. Greg Piepel|
|Category :||Individual Consumer|
| Greater access to Plan B does not reduce surgical abortions according to a recent report. One of the studies from Scotland reported that "in Glasgow , morning-after pill prescriptions increased 300 percent from 1992 to 1999. Yet, abortions did not decrease. In Lothian, where schools handed out condoms and sent pupils to clinics for morning-after pills, teenage pregnancies among 13 to 15- year-olds soared 10 percent in one year."
Research from the UK also revealed that over the counter access to Plan B "coincides with surges in STD rates. In areas where a limited program began in 1999 . . . chlamydia cases rose from 7,000 in 1999 to 10,000 cases in 2002. Gonorrhea cases climbed nearly 50 percent, to nearly 3,000 cases in 2002 . . . Abortions increased by nearly 6,000 in a one year period, jumping 3.2 percent in 2003 from 2002, with the largest leap among girls under the age of 16."
In summary, the above indicates that making Plan B available over the counter would likely do more to de-grade the public health than help it. Also, if conception has already occurred before Plan B is taken, a chemical abortion occurs. Abortions should not be legal at all, if as long as they are, drugs to induce abortions should remain prescription only.